Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

28.07

-0.80 (-2.77%)

At close: Mar 9, 2026, 4:00 PM EDT

28.60

+0.53 (1.89%)

After-hours: Mar 9, 2026, 5:09 PM EDT

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.58	56.75	32.79	24.46	18.89
Short-Term Investments	114.38	20.58	24.15	33.75	106.08
Cash & Short-Term Investments	154.96	77.32	56.93	58.21	124.97
Cash Growth	100.41%	35.81%	-2.19%	-53.42%	117.99%
Accounts Receivable	51.76	41.62	30.55	40.32	15.47
Inventory	11.51	6	5.52	9.12	6.62
Other Current Assets	21.94	10.17	6.26	8.26	7.41
Total Current Assets	240.17	135.1	99.27	115.9	154.47
Net Property, Plant & Equipment	0.92	0.25	1.03	2.79	11.89
Other Intangible Assets	24.75	27.1	13.88	14.95	-
Other Long-Term Assets	247.76	1.53	3.06	0.64	0.97
Total Assets	513.59	163.98	117.23	134.28	167.33
Accounts Payable	7.19	3.34	7.14	22.51	3.8
Accrued Expenses	28.9	25.96	17.52	23.06	25.85
Current Portion of Long-Term Debt	29.81	7.27	7.23	-	-
Current Portion of Leases	0.61	0.29	0.69	1.13	9.89
Unearned Revenue	-	-	1.36	1.37	2.6
Other Current Liabilities	32.72	26.44	19.33	17.14	21.42
Total Current Liabilities	99.24	63.3	53.27	65.21	63.55
Long-Term Debt	22.48	52.41	52.37	39.45	19.91
Long-Term Leases	0.4	-	0.29	0.97	0.76
Other Long-Term Liabilities	-	44.98	39.94	42.26	52.73
Total Long-Term Liabilities	22.88	97.39	92.6	82.68	73.4
Total Liabilities	122.11	160.69	145.87	147.9	136.95
Common Stock	0.02	0.02	0.02	0.17	0.17
Additional Paid-in Capital	1,414	1,393	1,379	1,369	1,354
Accumulated Other Comprehensive Income	0.18	0.01	0.01	-0.15	-0.1
Retained Earnings	-1,023	-1,390	-1,408	-1,382	-1,324
Shareholders' Equity	391.48	3.29	-28.64	-13.62	30.37
Total Liabilities & Equity	513.59	163.98	117.23	134.28	167.33
Total Debt	53.3	59.97	60.58	41.55	30.57
Net Cash (Debt)	101.65	17.36	-3.65	16.65	94.4
Net Cash Growth	485.69%	-	-	-82.36%	417.56%
Net Cash Per Share	5.40	0.98	-0.21	0.98	5.54
Book Value	391.48	3.29	-28.64	-13.62	30.37
Book Value Per Share	20.78	0.19	-1.65	-0.80	1.78
Tangible Book Value	366.73	-23.81	-42.52	-28.57	30.37
Tangible Book Value Per Share	19.47	-1.35	-2.44	-1.68	1.78

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q